Biotic components as an alternative for the improvement of dermatological diseases. Descriptive review
DOI:
https://doi.org/10.32776/revbiomed.v37.i2.1365Keywords:
Skin, microbiota, dysbiosis, probiotics, prebiotics, postbiotics, dermatological productsAbstract
The skin is the largest and most extensive organ in the human body and forms the boundary between the individual and their environment. The skin's microbiota is closely linked to it and plays various roles in dermatological health. Skin dysbiosis, characterized by changes in the diversity and quantity of microorganisms, leads to skin diseases. Over the past decade, there has been a significant increase in the number of patients presenting with skin disorders resulting from dysbiosis. Furthermore, it has been suggested that biotic components can restore skin dysbiosis. The objective of this review is therefore to analyze the effect of such components, including probiotics, prebiotics, symbiotics, and postbiotics, in counteracting skin dysbiosis and restoring the skin microbiota. Studies published in PubMed, SciELO and Google Scholar between 2020 and 2025 were included in the search, using the keywords “biotic components” and “dermatological diseases” in English or Spanish. This descriptive review examined biotic components incorporated into dermatological products to treat conditions such as acne, atopic dermatitis, seborrheic dermatitis, rosacea, psoriasis and skin cancer. In conclusion, dermatological products fortified with probiotics, prebiotics and/or postbiotics offer therapeutic potential for treating skin conditions and improving skin aesthetics
References
1.- Potbhare R, RaviKumar A, Munukka E, Lahti L, Ashma R. Skin microbiota diversity among genetically unrelated individuals of Indian origin. PeerJ. 2022 Mar 16; 10:e13075. doi: 10.7717/peerj.13075
2.- Timm CM, Loomis K, Stone W, Mehoke T, Brensinger B, Pelletier DA, et al. Isolation and characterization of diverse microbial representatives from the human skin microbiome. Microbiome. 2020 Apr 22; 8(1):58. doi: 10.1186/s40168-020-00831-y
3.- Pereira MS, Redanz S, Kriegel MA. Skin deep: the role of the microbiota in cutaneous autoimmunity. J Invest Dermatol. 2022 Mar;142(3 Pt B):834-40. doi: 10.1016/j.jid.2021.12.005
4.- Medina-Castillo DE, Pérez-López JA, Aguilar-Medina DA, de la Cruz-Medina R. Microbioma, acné y probióticos orales. Dermatol Rev Mex. 2024;68(1):51-63. doi: 10.24245/drm/bmu.v68i1.9475
5.- Ito Y, Amagai M. Dissecting skin microbiota and microenvironment for the development of therapeutic strategies. Curr Opin Microbiol. 2023 Aug; 74:102311. doi:10.1016/j.mib.2023.102311
6.- Cancino JC. Cancino Díaz JC, Cancino Díaz ME, Rodríguez Martínez S, Castañeda Sánchez JI, editores. Staphylococcus epidermidis: desde la inocuidad hasta la patogenia. 1.ª ed. Ciudad de México: Universidad Autónoma Metropolitana, 2024. Pp. 380
ISBN: 9786072831100. Disponible en: https://repositorio.xoc.uam.mx/jspui/handle/123456789/43962
7.- Skowron K, Bauza-Kaszewska J, Kraszewska Z, Wiktorczyk-Kapischke N, Grudlewska-Buda K, Kwiecińska-Piróg J, Wałecka-Zacharska E, Radtke L, Gospodarek-Komkowska E. Human skin sicrobiome: impact of intrinsic and extrinsic factors on skin microbiota. Microorganisms. 2021 Mar 5; 9(3):543. doi: 10.3390/microorganisms9030543
8.- Celorio-Murillo WJ, Benavides-Tulcán E. Probióticos y prebióticos: beneficios en dermatología. Rev Chil Dermatol. 2021. 31 (1): 6-11. doi: 10.31879/rcderm.v37i1.364
9.- Pérez-Chabela ML, Yenizey M, Soriano-Santos J, Pérez-Hernández MA. Los probióticos y sus metabolitos en la acuicultura. Una revisión. Hidrobiológica. 2020 oct 1; 30(1):93–105. doi: 10.24275/uam/izt/dcbs/hidro/2020v30n1/perez
10.- Gurunathan S, Thangaraj P, Kim JH. Postbiotics: functional food materials and therapeutic agents for cancer, diabetes, and inflammatory diseases. Foods. 2023 Dec 26; 13(1):89. doi: 10.3390/foods13010089
11.- Vinderola G, Sanders ME, Cunningham M, Hill C. Frequently asked questions about the ISAPP postbiotic definition. Front Microbiol. 2024 Jan 10; 14:1324565. doi: 10.3389/fmicb.2023.1324565
12.- Podwojniak A, Tan IJ, Sauer J, Neubauer Z, Rothenberg H, Ghani H, et al. Acne and the cutaneous microbiome: a systematic review of mechanisms and implications for treatments. J Eur Acad Dermatol Venereol. 2025 Apr; 39(4): 793-805. doi: 10.1111/jdv.20332
13.- Sánchez-Pellicer P, Navarro-Moratalla L, Núñez-Delegido E, Ruzafa-Costas B, Agüera-Santos J, Navarro-López V. Acne, microbiome, and probiotics: The gut–skin axis. Microorganisms. 2022 Jun 27; 10(7): 1303. doi: 10.3390/microorganisms10071303
14.- Han HS, Shin SH, Choi BY, Koo N, Lim S, Son D, et al. A split face study on the effect of an anti-acne product containing fermentation products of Enterococcus faecalis CBT SL-5 on skin microbiome modification and acne improvement. J Microbiol. 2022 May; 60(5): 488-495. doi: 10.1007/s12275-022-1520-6
15.- Podrini C, Schramm L, Marianantoni G, Apolinarska J, McGuckin C, Forraz N, et al. Topical administration of Lactiplantibacillus plantarum (SkinDuoTM) serum improves anti-acne properties. Microorganisms. 2023 Feb 7; 11(2):4 17. doi: 10.3390/microorganisms11020417
16.-Pachacama-López AF, Tapia-Portilla MF, Moreno-Piedrahíta Hernández F, Palacios-Álvarez S. Uso de probióticos para disminuir la gravedad de la dermatitis atópica en población pediátrica: revisión sistemática y metaanálisis. Actas Dermosifiliogr. 2021 oct; 112(10): 881–90. doi: 10.1016/j.ad.2021.06.006
17.- Friedrich AD, Campo VE, Cela EM, Morelli AE, Shufesky WJ, Tckacheva OA, et al. Oral administration of lipoteichoic acid from Lactobacillus rhamnosus GG overcomes UVB-induced immunosuppression and impairs skin tumor growth in mice. Eur J Immunol. 2019 Nov; 49(11): 2095-2102. doi: 10.1002/eji.201848024
18.- Nakatsuji T, Chen TH, Butcher AM, Trzoss LL, Nam S-J, Shirakawa KT, et al. A
A commensal strain of Staphylococcus epidermidis protects against skin neoplasia. Sci Adv. 2018 Feb 28; 4(2): eaao4502. doi: 10.1126/sciadv.aao4502
19. Sugimoto, T., Atobe, S., Kado, Y., Takahashi, A., Motoori, M., Sugimura, K., Miyata, H., Yano, M., Tanaka, K., Doki, Y., Shiraishi, O., Yasuda, T., & Asahara, T. (2023). Gut microbiota associated with the mitigation effect of synbiotics on adverse events of neoadjuvant chemotherapy in patients with esophageal cancer: A retrospective exploratory study. J Med Microbiol. 2023 Jun; 72(6). doi: 10.1099/jmm.0.001723
20.- Patra VK, Gallais Sérézal I, Wolf P. Potential of skin microbiome, pro- and/or pre-biotics to affect local cutaneous responses to UV exposure. Nutrients. 2020 Jun 17; 12(6): 1795. doi: 10.3390/nu12061795
21.- Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med (Lond). 2021 May; 21(3): 170-173. doi: 10.7861/clinmed. 2021-0257
22.- Barquero-Orias D, Muñoz Moreno-Arrones O, Vañó-Galván S. Alopecia y microbioma: ¿futura diana terapéutica? Actas Dermosifiliogr. 2021 Mar 19; 112(6): 495-502. doi: 10.1016/j.ad.2020.12.005
23.- Hui Lu, Ting Hong, Yuanying Jiang, Malcolm Whiteway, Shiqun Zhang. Candidiasis: from cutaneous to systemic, new perspectives of potential targets and therapeutic strategies. Adv Drug Deliv Rev. 2023 Jun; 199: 114960. doi: 10.1016/j.addr.2023.114960
24.- Reygagne, P., Bastien, P., Couavoux, M. P., Philippe, D., Renouf, M., Castiel-Higounenc, I., & Gueniche, A. (2017). The positive benefit of Lactobacillus paracasei NCC2461 ST11 in healthy volunteers with moderate to severe dandruff. Benef Microbes. 2017 Oct 13; 8(5): 671-680. doi: 10.3920/BM2016.0144
25.- Borda LJ, Perper M, Keri JE. Treatment of seborrheic dermatitis: a comprehensive review. J Dermatolog Treat. 2019 Mar; 30(2): 158-169. doi: 10.1080/09546634.2018.1473554.
26.- Vidal SI, Menta N, Green L. Dermatitis seborreica en niños y adultos: Una revisión narrativa del panorama actual de tratamientos. Dermatol Ther (Heidelb) 2025 Mar; 15: 599–613. doi: 10.1007/s13555-025-01351-z
27.- Zareie E, Mansouri P, Hosseini H, Sadeghpour O, Shirbeigi L, Hejazi S, Emtiazy M. Effect of oral administration of Triphala, a polyphenol-rich prebiotic, on scalp sebum in patients with scalp seborrhea: a randomized clinical trial. J Dermatolog Treat. 2022 Mar; 33(2): 1011-1016. doi: 10.1080/09546634.2020.1800568
28.- Jusuf NK, Putra IB, Sari L. Differences of microbiomes found in non-inflammatory and inflammatory lesions of acne vulgaris. Clin Cosmet Investig Dermatol. 2020 Oct 22; 13: 773-780. doi: 10.2147/CCID.S272334
29.- Fabbrocini G, Bertona M, Picazo Ó, Pareja-Galeano H, Monfrecola G, Emanuele E. Supplementation with Lactobacillus rhamnosus SP1 normalizes skin expression of genes implicated in insulin signaling and improves adult acne. Benef Microbes. 2016 Nov 30; 7(5): 625-630. doi:
10.3920/BM2016.0089
30.- Jung GW, Tse JE, Guiha I, Rao J. Prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne. J Cutan Med Surg. 2013 Mar-Apr; 17(2): 114-22. doi: 10.2310/7750.2012.12026
31.- Kang BS, Seo JG, Lee GS, Kim JH, Kim SY, Han YW, Kang H, Kim HO, Rhee JH, Chung MJ, et al. Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect. J Microbiol. 2009 Feb; 47(1): 101-9. doi: 10.1007/s12275-008-0179-y
32.- Kim J, Ko Y, Park YK, Kim NI, Ha WK, Cho Y. Dietary effect of lactoferrin-enriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris. Nutrition. 2010 Sep; 26(9): 902-9. doi: 10.1016/j.nut.2010.05.011
33.- Ordóñez Rojas, N., Orellana Cifuentes, J., Blacio Arce, E., Jiménez Soto, R., & Briones Morales, V. (2024). Utilidad de probióticos y vitaminas en el tratamiento de dermatitis atópica en la población general. Polo Conoc. 9(9): 654-71. doi:https://doi.org/10.23857/pc.v9i9.7954
34.- Climent E, Martínez-Blanch JF, Llobregat L, Ruzafa-Costas B, Carrión-Gutiérrez MN, Ramírez-Boscá A, et al. Changes in gut microbiota correlates with response to treatment with probiotics in patients with atopic dermatitis. a post hoc analysis of a clinical trial. Microorganisms. 2021 Apr 15; 9(4): 854. doi: 10.3390/microorganisms9040854
35.- Navarro-López V, Ramírez-Boscá A, Ramón-Vidal D, Ruzafa-Costas B, Genovés-Martínez S, et al. Effect of oral administration of a mixture of probiotic strains on scorad index and use of topical steroids in young patients with moderate atopic dermatitis. JAMA Dermatol. 2018 Jan 1; 154(1): 37-43. doi: 10.1001/jamadermatol.2017.3647
36.- Blanchet-Réthoré S, Bourdès V, Mercenier A, Haddar CH, Verhoeven PO, Andres P. Effect of a lotion containing the heat-treated probiotic strain Lactobacillus johnsonii NCC 533 on Staphylococcus aureus colonization in atopic dermatitis. Clin Cosmet Investig Dermatol. 2017 Jul 3; 10:249-257. doi: 10.2147/CCID.S135529
37.- Sistek D, Kelly R, Wickens K, Stanley T, Fitzharris P, Crane J. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin Exp Allergy. 2006 May; 36(5): 629-33. doi: 10.1111/j.1365-2222.2006.02485.x
38.- Weston S. Effects of probiotics on atopic dermatitis: a randomized controlled trial. Arch Dis Child. 2005 Sep; 90(9): 892-7. doi: 10.1136 /adc.2004.060673
39.- Yu Y, Dunaway S, Champer J, Kim J, Alikhan A. Changing our microbiome: probiotics in dermatology. Br J Dermatol. 2020 Jan; 182(1):39-46. doi: 10.1111/bjd.18088
40.- Leroy AK, Cortez de Almeida RF, Obadia DL, Frattini S, Melo DF. Scalp Seborrheic Dermatitis: what we know so far. Skin Appendage Disord. 2023 Jun; 9(3):160-164. doi: 10.1159/000529854
41.- Galizia G, Belloni Fortina A, Semenzato A. Seborrheic dermatitis: from microbiome and skin barrier Involvement to emerging approaches in dermocosmetic treatment. Cosmetics. 2024 Nov; 11(6): 208. doi:10.3390/cosmetics11060208
42.- Tsai WH, Fang YT, Huang TY, Chiang YJ, Lin CG, Chang WW. Heat-killed Lacticaseibacillus paracasei GMNL-653 ameliorates human scalp health by regulating scalp microbiome. BMC Microbiol. 2023 Apr 29; 23(1): 121. doi: 10.1186/s12866-023-02870-5
43.- Feng C, Zhang H, Wang P, Zhang L, Liu X, Yan G, et al. Oroxylin A suppress LL-37 generated rosacea-like skin inflammation through the modulation of SIRT3-SOD2-NF-κB signaling pathway. Int Immunopharmacol. 2024 Mar 10; 129: 111636. doi: 10.1016/j.intimp.2024.111636
44.- Manfredini M, Barbieri M, Milandri M, Longo C. Probiotics and diet in rosacea: current evidence and future perspectives. Biomolecules. 2025 Mar 13; 15(3): 411. doi: 10.3390/biom15030411
45.- Kim MS, Kim JE, Yoon YS, Seo JG, Chung MJ, Yum DY. A Probiotic Preparation Alleviates Atopic Dermatitis-Like Skin Lesions in Murine Models. Toxicol Res. 2016 Apr; 32(2): 149-58. doi: 10.5487/TR.2016.32.2.149
46.- Morgado-Carrasco D, Gil-Lianes J, Jourdain E, Piquero-Casals J. Oral supplementation and systemic drugs for skin aging: a narrative review. Actas Dermosifiliogr. 2023 Feb; 114(2): 114-124. doi: 10.1016/j.ad.2022.09.014
47.- Birnbaum J, Le Moigne A, Dispensa L, Buchner L. A review of clinical trials conducted with oral, multicomponent dietary supplements for improving photoaged skin. J Drugs Dermatol. 2015 Dec; 14(12): 1453-61.
48.- Ariztizábal PA, Lopera MM. Psoriasis: una mirada actual a su patogenia y biomarcadores. Dermatol Rev Mex. 2024; 68(3): 344-57. doi: 10.24245/drm/bmu.v68i3.9777
49.- Groeger D, O'Mahony L, Murphy EF, Bourke JF, Dinan TG, Kiely B, Shanahan F, Quigley EM. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes. 2013 Jul-Aug; 4(4): 325-39. doi: 10.4161/gmic. 25487
50. Vijayashankar M, Raghunath N. Pustular psoriasis responding to probiotics – a new insight. Our Dermatol Online. 2012 Jun 11; 3(4): 326–329. doi:10.7241/ourd.20124.71
51.- Deng Y, Fang Z, Cui S, Zhao J, Zhang H, Chen W, Lu W. Evaluation of probiotics for inhibiting hyperproliferation and inflammation relevant to psoriasis in vitro. J Functional Foods, 2021; 81: 104433. doi:10.1016/j.jff.2021.104433
52.- Darias-Domínguez C, Ramírez-Fernández M. Caracterización del fotoenvejecimiento en consulta de Dermatología. Rev Med Electrón. 2023 Ago 31; 45(4): 604-616. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684-18242023000400604&lng=es
53.- Buhaș MC, Candrea R, Gavrilaș LI, Miere D, Tătaru A, Boca A, Cătinean A. Transforming psoriasis care: probiotics and prebiotics as novel therapeutic approaches. Int J Mol Sci. 2023 Jul 7; 24(13): 11225. doi: 10.3390/ijms241311225
54.- Fernández-Ruiz M, Mosqueda-Peña R, Pérez-Ayala A, Blázquez-Gamero D. Congenital cutaneous candidiasis associated with maternal peripartum candidemia. Rev Iberoam Micol. 2020 Apr-Jun; 37(2): 68-71. doi: 10.1016/j.riam.2020.02.002
55.- Bouopda-Tamo SP. Candida infections: clinical features, diagnosis and treatment. Infect Dis Clin Microbiol. 2020 Aug 31; 2(2):91–102. doi:10.36519/idcm.2020.0006
56.- Gits‑Muselli M, Hamane S, Benderdouche M. Dermatomicosis. EMC – Tratado de Medicina. 2020; 24(3): 1–12. doi:10.1016/S1636-5410(20)44020
57.- Kimoto-Nira H, Aoki R, Sasaki K, Suzuki C, Mizumachi K. Oral intake of heat-killed cells of Lactococcus lactis strain H61 promotes skin health in women. J Nutr Sci. 2012 Dec 6; 1: e18. doi: 10.1017/jns.2012.22
58.- Sibbald C. Alopecia areata: An updated review for 2023. J Cutan Med Surg. 2023 May-Jun; 27(3): 241-59. doi: 10.1177/12034754231168839
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Janet - Jan Roblero, Brenda Sofía Loaeza Cruz, Paola Aguilar Fortanell, Luis Fernando Hernández Santos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Those authors who have publications with this magazine accept the following terms:
Authors will keep their copyright and guarantee the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons Recognition License that allows third parties to share the work whenever its author is indicated and his first publication in this magazine. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (eg, deposit it in an institutional telematic file or publish it in a monographic volume) whenever the initial publication in this journal is indicated. Authors are allowed and advised to disseminate their work through the Internet (eg in institutional telematic archives or on their website) after the submission has been accepted and published, which can produce interesting exchanges and increase citations of the published work.
(See The effect of open access)
